Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-18

FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for citalopram hydrobromide from Camber Pharmaceuticals, indicating regulatory action related to this generic antide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram Hydrobromide (citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE)